General

The following information should be read in conjunction with the financial statements and the notes thereto appearing elsewhere in this report.

Disclosure Regarding Forward-Looking Statements





Certain statements made in this report, and other written or oral statements
made by or on behalf of the Company, may constitute "forward-looking statements"
within the meaning of the federal securities laws. When used in this report, the
words "believes," "expects," "estimates," "intends," and similar expressions are
intended to identify forward-looking statements. Statements regarding future
events and developments and our future performance, as well as our expectations,
beliefs, plans, intentions, estimates, or projections relating to the future,
are forward-looking statements within the meaning of these laws. Examples of
such statements in this report include descriptions of our plans and strategies
with respect to developing certain market opportunities, and our overall
business plan. All forward-looking statements are subject to certain risks and
uncertainties that could cause actual events to differ materially from those
projected we believe that these forward-looking statements are reasonable;
however, you should not place undue reliance on such statements. These
statements are based on current expectations and speak only as of the date of
such statements. We undertake no obligations to publicly update or revise any
forward-looking statement, whether as a result of future events, new information
or otherwise.



                                       16





Background



Innovative Designs, Inc. (hereafter referred to as the "Company", "we" or "our")
produces and sells a house wrap product using Insultex a material with thermal
resistance and buoyancy properties. We also offer a cold weather product line
called "Artic Armor" which also uses Insultex. We no longer produce any Artic
Armor products. We are only selling form our existing inventory. We obtain
Insultex through a license agreement with the owner and manufacturer of the
material. In December 2015, we took delivery of equipment capable of producing
our own Insultex. At such time as we have sufficient funding, we intend put the
equipment into production and use the Insultex from this equipment in the
production of our House Wrap product and for the sale of Insultex to others.



Results of Operations


Comparison of the fiscal year ended October 31, 2022, with the fiscal year ended October 31, 2021.

The following table shows a comparison of the results of operations between the fiscal years ended October 31, 2022 and October 31, 2021:





                                    Fiscal Year                   Fiscal Year
                                       Ended                         Ended
                                    October 31,        % of       October 31,        % of        Increase        %
                                        2022          Sales           2021          Sales       (Decrease)     Change

REVENUE                            $    258,734       100.00 %   $    225,601       100.00 %   $   33,133         15 %

OPERATING EXPENSES
Cost of sales                           118,997           46 %         96,728           43 %       22,269         23 %
Selling, general
and administrative expenses             666,239          257 %        411,716          182 %      254,523         62 %
                                        785,236         -303 %        508,444          225 %      276,792         54 %
Loss from operations                   (526,502 )       -203 %       (282,843 )       -125 %     (243,659 )       86 %

OTHER INCOME/(EXPENSE)
Other income                            371,000          143 %         33,652           15 %      337,348       1002 %
Interest expense                        (42,072 )        -16 %        (49,112 )        -22 %        7,040        -14 %
Loss on disposal of equipment               -0-            0 %        (24,429 )        -11 %      (24,429 )      100 %

Net loss                           $   (197,574 )        -76 %   $   (322,732 )       -143 %   $  125,158        -39 %

Weighted average common shares
outstanding - undiluted              34,650,560                    32,263,560

Loss per common share -
undiluted                          $      (0.01 )                $      (0.01 )




                                       17





Results of Operations



Revenues for the fiscal year ended October 31, 2022, were $ 258,734 compared to
revenues of $225,601 for the comparable period ending October 31, 2021. House
Wrap product revenue totaled $ 193,302 for the period compared to $169,375 for
fiscal year ended October 31, 2022. Nearly all of the remaining revenues were
derived from our Arctic Armor and related product lines which totaled $65,432
for the period compared to revenues of $56,226 for the fiscal year ended October
31, 2021. Revenues are net of returns and discounts. We continue to work on
rebuilding our House Wrap product line brand after doing no advertising during
the time of the FTC litigation, November 2016 to July 2021, and the effect of
the litigation on our House Wrap products acceptance, and the use of Insultex in
other applications in the marketplace.



Selling, general and administrative expense increased from $411,716 in fiscal
year 2021, to $666,239 in the fiscal year ending October 31, 2022. This increase
reflects, in part, $53,000 more for advertising and marketing, a payroll
increase of $75,000, a reinstatement fee of $14,000 for listing on the OTCQB and
stock base compensation to our directors of $71,000 and $75,000 in stock based
compensation to a marketing consultant. Profession fees decreased during the
period by $17,000 as the FTC litigation wound down.



Our cost of sales increased from $96,728 as of October 31, 2021, to $118,997 as of October 31, 2022.

Liquidity and Capital Resources





During the fiscal year ended October 31, 2022, we funded our operations from
revenues, a legal settlement and the private sales of our common stock. During
the period, we received $260,000 from a settlement with the FTC for legal fees
incurred in connection with the FTC litigation. Subsequent to the period, we
receive $110,000 from the sale of our Common Stock. We will continue to fund our
operations from revenues, private borrowings and the sale of our common stock
until we are able to produce sales sufficient to cover our cost structure or to
secure commercial lending arrangements.



On July 12, 2015, the Company reached an agreement with Ketut Jaya to purchase
machinery and equipment utilized to produce the INSULTEX material. The purchase
price is $700,000 and to be made in four installments. The first installment of
$300,000 is to be made at the execution of the agreement. The second installment
of $200,000 is to be made when the machinery and equipment is ready to be
shipped to the United States. The third installment of $100,000 is to be made
once the machinery and equipment is producing INSULTEX, and the fourth and final
installment of $100,000 is to be made after the first commercial production run
of INSULTEX is completed. As of October 31, 2016, the Company has made payments
of $600,000. In addition to the final payments, the Company will have to have
the equipment and machines installed and ensure that the machine can be operated
in compliance with environmental regulations. The Company has not made an
estimate of the costs required for bringing the machine into compliance, but it
is considered to be substantial. Given the expected time and cost of bringing
the equipment into production mode and our current financial condition we are
unable to estimate when we will be able to do so.



We also must purchase new quality control testing equipment for our House Wrap
product line which we estimate will cost approximately $100,000. However, we
have not as yet received a quote from the vendor. We have placed a $7,000
deposit with the vendor. Once the equipment is built it will have to go through
a certification process.


During the period we paid $144,666 on our loans.





Short Term: We funded our operations with revenues from sales, private sales of
our common stock and from a legal settlement. We could not access commercial
lines of credit during our last fiscal year.



                                       18





The Company intends to repay these debt obligations with funds it generates from
revenues, from the possible sale of its securities either debt or equity, from
advances from our stockholders or others. Because we cannot currently access
commercial lending facilities, should we not be able to continue to obtain
funding from these sources should our revenues decrease, our operations would be
severely affected as we would not be able to fund our purchase orders to our
suppliers for finished goods. The Company continues to pay its creditors when
payments are due.



Long Term: The Company will continue to fund operations from revenues,
borrowings and the possible sale of its securities. Should we not be able to
continue to rely on these sources our operations would be severely affected as
we would not be able to fund our purchase orders to our suppliers for finished
goods.

© Edgar Online, source Glimpses